1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant TherapyNeoplasms by Site, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, glucose metabolism disease, hyperinsulinism, metabolic disease, neoplasm, skin disorderRecruitingPhase 12026-05-22NCT05989347